Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,233.66 -13.27 (-1.06%)

Official Closing Price Updated: 6:30 PM EDT, Aug 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

2 Stocks That Could Capitalize on the GLP-1 Boom ↗

Today 15:38 EDT

They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

Via The Motley Fool

Which Healthcare ETF Is the Better Buy: Vanguard's VHT or iShares' IXJ? ↗

Today 13:58 EDT

VHT charges low fees and holds more than 400 stocks for broader diversification. IXJ's portfolio of 110 holdings includes international exposure -- but comes at a higher cost.

Via The Motley Fool

Topics ETFs

2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down

Today 0:35 EDT

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

Topics Economy Energy

Eli Lilly (NYSE:LLY): A Dividend Quality Pick with Sustainable Growth ↗

August 24, 2026

Via Chartmill

Eli Lilly (NYSE:LLY) Shows Strong Growth and a Compelling Technical Setup ↗

August 21, 2026

Via Chartmill

3 Growth Stocks That Could Skyrocket in the Second Half of 2026 ↗

August 23, 2026

Here are three growth leaders with strong tailwinds: Arista Networks, Micron, and Eli Lilly.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can ↗

August 23, 2026

Could this little-known biotech be a hidden gem?

Via The Motley Fool

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors? ↗

August 23, 2026

Here's how Invesco's concentrated pharma play compares to Fidelity's diversified approach to healthcare stocks.

Via The Motley Fool

Topics ETFs

Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You? ↗

August 23, 2026

Griffin's Q2 move is already paying off nicely.

Via The Motley Fool

2 Biotech Stocks Shaping Up for Major Breakouts ↗

August 22, 2026

Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts.

Via MarketBeat

Topics ETFs

Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? ↗

August 21, 2026

IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk.

Via The Motley Fool

Topics ETFs

Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 5 Years ↗

August 21, 2026

Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 25.41% on an annualized basis producing an average annual return of 36.72%. Currently, Eli Lilly has a market capitalization of...

Via Benzinga

Stock Split Watch: Is Eli Lilly (LLY) Stock Next? ↗

August 21, 2026

Shares recently traded at $1,280 each, so a split wouldn't be surprising.

Via The Motley Fool

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? ↗

August 20, 2026

VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.

Via The Motley Fool

Topics ETFs

There’s a Black Market for Eli Lilly’s Unapproved GLP-1 Drug. Here’s Why That’s Bullish ↗

August 20, 2026

Can anyone challenge Eli Lilly in the weight loss space?

Via The Motley Fool

Topics Intellectual Property Lawsuit

IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? ↗

August 20, 2026

XBI is up nearly 80% over the past year, but has experienced a much larger maximum drawdown over the past five years. IHE has delivered steadier returns and offers a higher dividend yield.

Via The Motley Fool

Topics ETFs

Could Eli Lilly Be Worth More Than SpaceX by the End of 2026? ↗

August 19, 2026

These two stocks both have market caps of more than $1 trillion, but Eli Lilly's valuation is supported by strong financials.

Via The Motley Fool

Absci (ABSI) Q2 2026 Earnings Call Transcript ↗

August 19, 2026

Biotech extends runway to 2028 with $100M financing and Eli Lilly deal.

Via The Motley Fool

Topics Earnings

Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market ↗

August 19, 2026

The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion obesity market.

Via Investor's Business Daily

Netflix, Eli Lilly, Elanco Animal Health And More Stock On CNBC’s ‘Final Trades’ ↗

August 19, 2026

Bryn Talkington picked Horizon Kinetics, Stephanie Link chose Elanco Animal Health, and Jason Snipe recommended Netflix.

Via Benzinga

Why Eli Lilly (LLY) Stock Is Up Today

August 18, 2026

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3% in the afternoon session after the company announced two deals, acquiri...

Via StockStory

Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? ↗

August 18, 2026

PPH offers the income and stability of proven pharmaceutical leaders while XBI swings for the fences across 155 smaller biotech names.

Via The Motley Fool

Topics ETFs

PPH vs. IYH: Which Healthcare Fund Is the Better Buy? ↗

August 18, 2026

PPH concentrates on just 26 drugmakers, while IYH diversifies more broadly across 100 healthcare holdings.

Via The Motley Fool

Topics ETFs

U.S. Physical Therapy Names Nchacha Etta as Chief Financial Officer /www.snipeso ↗

August 18, 2026

Outpatient physical therapy operators regularly strengthen their executive leadership to support long-term operational scaling and strategic financial mana

Via Talk Markets

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now ↗

August 18, 2026

Novo Nordisk, CVS Health, and Bristol Myers are top dividend stocks that are trading at modest valuations.

Via The Motley Fool

If I Were in My 20s, I'd Buy This Unstoppable Vanguard ETF and Hold It Forever ↗

August 18, 2026

Investors can reap big rewards over the long term by betting on growth in their younger years.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

Why Is Omniab Stock Rallying After Eli Lilly Deal? ↗

August 17, 2026

The OmniAb Lilly Deal offers up to $370 million in milestones as OABI raises its 2026 cash outlook and shares jump premarket

Via Benzinga

Wall Street Says the Stock Market's Return Will Crush the Long-Term Average in the Next Year ↗

August 17, 2026

The S&P 500 returned 9.5% annually over the past two decades. Wall Street expects much bigger gains in the next year.

Via The Motley Fool

Topics Stocks

1 of Wall Street’s Favorite Stocks on Our Watchlist and 2 We Find Risky

August 17, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

2 GLP-1 Stocks That Could Double Your Money by 2031 ↗

August 16, 2026

They are fairly risky, but their potential upside is massive.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Eli Lilly (NY:LLY)

Headline News about Eli Lilly

Starting at /week.